Tango Therapeutics, Inc. (TNGX)
26.65
+1.61
(+6.43%)
USD |
NASDAQ |
Apr 17, 16:00
26.80
+0.15
(+0.56%)
After-Hours: 16:43
Tango Therapeutics Free Cash Flow : -139.93M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Revolution Medicines, Inc. | -913.73M |
| Kodiak Sciences, Inc. | -136.51M |
| Hims & Hers Health, Inc. | 57.42M |
| Recursion Pharmaceuticals, Inc. | -380.44M |
| Terns Pharmaceuticals, Inc. | -82.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.72M |
| Cash from Investing (Quarterly) | -135.72M |
| Cash from Financing (Quarterly) | 219.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2275 |
| Free Cash Flow to Equity (Quarterly) | -28.75M |
| Free Cash Flow to Firm (Quarterly) | -29.94M |
| Free Cash Flow Yield | -4.53% |